Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Tumor Suppressor Protein p53. Found 19 abstracts

Pollack A, Kwon D, Walker G, Khor LY, Horwitz EM, Buyyounouski MK, Stoyanova R. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer. Journal of the National Cancer Institute. 2017 Feb;109(2):1-8.   PMCID: PMC6075027
Zhou G, Pantelopulos GA, Mukherjee S, Voelz VA. Bridging Microscopic and Macroscopic Mechanisms of p53-MDM2 Binding with Kinetic Network Models. Biophysical journal. 2017 Aug 22;113(4):785-93.   PMCID: PMC5567610
Mukherjee S, Pantelopulos GA, Voelz VA. Markov models of the apo-MDM2 lid region reveal diffuse yet two-state binding dynamics and receptor poses for computational docking. Sci Rep. 2016 Aug 19;6:31631.   PMCID: PMC4990920
Prabhu VV, Hong B, Allen JE, Zhang S, Lulla AR, Dicker DT, El-Deiry WS. Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated DeltaNp73 Inhibition and p73 Activation. Cancer Res. 2016 Apr;76(7):1989-99.
Prudnikova TY, Villamar-Cruz O, Rawat SJ, Cai KQ, Chernoff J. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells. Oncogene. 2016 Apr 28;35(17):2178-85.   PMCID: PMC5125076
Skala E, Sitarek P, Toma M, Szemraj J, Radek M, Nieborowska-Skorska M, Skorski T, Wysokinska H, Sliwinski T. Inhibition of human glioma cell proliferation by altered Bax/Bcl-2-p53 expression and apoptosis induction by Rhaponticum carthamoides extracts from transformed and normal roots. The Journal of pharmacy and pharmacology. 2016 Nov;68(11):1454-64.
Fahl SP, Harris B, Coffey F, Wiest DL. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015 Jan;194(1):200-9.   PMCID: PMC4333014
Kung CP, Khaku S, Jennis M, Zhou Y, Murphy ME. Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res. 2015 Feb;13(2):250-62.   PMCID: PMC4336799
Masica DL, Li S, Douville C, Manola J, Ferris RL, Burtness B, Forastiere AA, Koch WM, Chung CH, Karchin R. Predicting survival in head and neck squamous cell carcinoma from TP53 mutation. Hum Genet. 2015 May;134(5):497-507.   PMCID: 4324386
Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res. 2010 Feb;70(3):1184-94.   PMCID: PMC2879282
Beeharry N, Yen TJ. p53-dependent apoptosis in response to spindle damage is linked to loss of Bub1. Cancer Biol Ther. 2009 Apr;8(7):645-7.
Cai KQ, Wu H, Klein-Szanto AJ, Xu XX. Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity. Gynecol Oncol. 2009 Jul;114(1):18-25.   PMCID: PMC2739736
Pimkina J, Murphy ME. ARF, autophagy and tumor suppression. Autophagy. 2009 Apr;5(3):397-9.   PMCID: PMC2667648
Rhodes J, Amsterdam A, Sanda T, Moreau LA, McKenna K, Heinrichs S, Ganem NJ, Ho KW, Neuberg DS, Johnston A, Ahn Y, Kutok JL, Hromas R, Wray J, Lee C, Murphy C, Radtke I, Downing JR, Fleming MD, MacConaill LE, Amatruda JF, Gutierrez A, Galinsky I, Stone RM, Ross EA, Pellman DS, Kanki JP, Look AT. Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression. Mol Cell Biol. 2009 Nov;29(21):5911-22.   PMCID: PMC2772726
Mu Z, Hachem P, Hensley H, Stoyanova R, Kwon HW, Hanlon AL, Agrawal S, Pollack A. Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo. The Prostate. 2008 May;68(6):599-609.
Pietsch EC, Perchiniak E, Canutescu AA, Wang G, Dunbrack RL, Murphy ME. Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. The Journal of biological chemistry. 2008 Jul 25;283(30):21294-304.   PMCID: PMC2475706
Pietsch EC, Sykes SM, McMahon SB, Murphy ME. The p53 family and programmed cell death. Oncogene. 2008 Oct 27;27(50):6507-21.   PMCID: PMC2657599
Murphy ME. Polymorphic variants in the p53 pathway. Cell death and differentiation. 2006 Jun;13(6):916-20.
Mu Z, Hachem P, Pollack A. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. The Prostate. 2005 Dec;65(4):331-40.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Tumor Suppressor Protein p53

Tumor Suppressor Protein p53 genetics metabolism Apoptosis Mice pathology Proto-Oncogene Proteins c-mdm2 chemistry Cell Proliferation physiology Mutation pharmacology Signal Transduction Tumor Cell Line Female Neoplastic Gene Expression Regulation Male Proto-Oncogene Proteins c-bcl-2 Prostatic Neoplasms Cyclin-Dependent Kinase Inhibitor p21 Xenograft Model Antitumor Assays biosynthesis drug effects Protein Binding Neoplasms Mitochondria Androgen Antagonists bcl-2-Associated X Protein Flow Cytometry drug therapy cytology Biological Models Cultured Cells Ovarian Neoplasms Fibroblasts Oligonucleotide Array Sequence Analysis HCT116 Cells Reverse Transcriptase Polymerase Chain Reaction Cell Cycle Checkpoints Combined Modality Therapy Cell Cycle Promoter Regions (Genetics) 0 (Tumor Suppressor Protein p53) Protein-Serine-Threonine Kinases analysis Genome p21-Activated Kinases Hormonal Antineoplastic Agents Molecular Sequence Data Head and Neck Neoplasms Tumor Stem Cell Assay Hematopoiesis Microdissection bcl-2 Homologous Antagonist-Killer Protein Estrogen Receptor alpha Estrogens Gene Knock-In Techniques Ribosomes RNA Interference Immunoblotting Colorectal Neoplasms apoptosis ROC Curve Antineoplastic Agents Protein Folding Phenotype Anti-Bacterial Agents 0 (Proto-Oncogene Proteins c-bcl-2) Embryonic Development Alleles alpha-Helical Protein Conformation Molecular Dynamics Simulation Antisense) 0 (DNA Chloroquine Neoplastic Stem Cells classification Glioma Nuclear Proteins Orchiectomy Cyclooxygenase 2 Ki-67 Antigen Molecular Docking Simulation G-Protein-Coupled Receptors im [Immunology] Antisense DNA Western Blotting Survival Analysis CD4-Positive T-Lymphocytes Rhaponticum carthamoides 0 (Cyclin-Dependent Kinase Inhibitor p21) Middle Aged Homeodomain Proteins ADP-Ribosylation Factor 1 blood Disease Progression Medicinal Plants Antisense Oligodeoxyribonucleotides Area Under Curve microbiology Non-US Gov't Research Support Breast Neoplasms Bax CD8-Positive T-Lymphocytes Agrobacterium Proto-Oncogene Proteins p21(ras) Fluorescence Microscopy Dose Fractionation embryology Site-Directed Mutagenesis Kinetics Trans-Activation (Genetics) p53 Genes ai [Antagonists & Inhibitors] Tumor Biomarkers abnormalities deficiency Myeloid Cells Nude Mice Carrier Proteins Follow-Up Studies Autophagy Prospective Studies Nonmammalian Embryo Gene Silencing V(D)J Recombination Estradiol Protein Isoforms Amino Acid Sequence Brain Neoplasms Bacterial Transformation Algorithms methods physiopathology Genetic Polymorphism ge [Genetics] Markov Chains Cell Cycle Proteins Plant Roots Protein Domains Prognosis Quinolines Phytogenic Antineoplastic Agents Neoplasm DNA Neoplasm Transplantation immunology Androgen Receptors Knockout Mice DNA EC 3-4-22 (Caspases) Immunoglobulin Class Switching
Last updated on Wednesday, February 05, 2020